49 results on '"Wei, Qingyi"'
Search Results
2. Mouse double minute 4 variants modify susceptibility to risk of recurrence in patients with squamous cell carcinoma of the oropharynx
3. Novel genetic variants in the P38MAPK pathway gene ZAK and susceptibility to lung cancer
4. Genetic variants in the metzincin metallopeptidase family genes predict melanoma survival
5. Functional genetic variants of XRCC4 and ERCC1 predict survival of gastric cancer patients treated with chemotherapy by regulating the gene expression
6. A functional variant at the miRNA binding site in E2F1 gene is associated with risk and tumor HPV16 status of oropharynx squamous cell carcinoma
7. Genetic variants in DDO and PEX5L in peroxisome‐related pathways predict non‐small cell lung cancer survival
8. Genetic polymorphisms in the microRNA binding-sites of the thymidylate synthase gene predict risk and survival in gastric cancer
9. Two novel PRKCI polymorphisms and prostate cancer risk in an Eastern Chinese Han population
10. Polymorphisms at the microRNA binding-site of the stem cell marker gene CD133 modify susceptibility to and survival of gastric cancer
11. Genetic variant rs16430 6bp > 0bp at the microRNA-binding site in TYMS and risk of sporadic breast cancer risk in non-hispanic white women aged ≤55 years
12. Association of genetic variants of FBXO32 and FOXO6 in the FOXO pathway with breast cancer risk
13. Functional Polymorphisms in the Insulin-like Binding Protein-3 Gene May Modulate Susceptibility to Differentiated Thyroid Carcinoma in Caucasian Americans
14. Combined Effects of E2F1 and E2F2 Polymorphisms on Risk and Early Onset of Squamous Cell Carcinoma of the Head and Neck
15. Genetic Variants of a BH3-Only Pro-Apoptotic Gene, PUMA, and Risk of HPV16-Associated Squamous Cell Carcinoma of the Head and Neck
16. Single Nucleotide Polymorphisms of Matrix Metallopeptidase 3 and Risk of Gliomas in a Chinese Han Population
17. Effects of MDM2 promoter polymorphisms and p53 codon 72 polymorphism on risk and age at onset of squamous cell carcinoma of the head and neck
18. Genetic variants of the peroxisome proliferator‐activated receptor (PPAR) signaling pathway genes and risk of pancreatic cancer
19. Genetic variants in PDSS1 and SLC16A6 of the ketone body metabolic pathway predict cutaneous melanoma-specific survival
20. Association between polymorphisms in the GSTA4 gene and risk of lung cancer: A case–control study in a Southeastern Chinese population
21. Nucleotide excision repair as a marker for susceptibility to tobacco-related cancers: A review of molecular epidemiological studies
22. Novel genetic variants inHDAC2andPPARGC1Aof the CREB‐binding protein pathway predict survival of non‐small‐cell lung cancer
23. A genetic variant within MDM4 3′UTR miRNA binding site is associated with HPV16‐positive tumors and survival of oropharyngeal cancer
24. Genetic variants in glutamine metabolic pathway genes predict cutaneous melanoma‐specific survival
25. Genetic variants in the liver kinase B1‐AMP‐activated protein kinase pathway genes and pancreatic cancer risk
26. Potentially functional genetic variants in the TNF/TNFR signaling pathway genes predict survival of patients with non‐small cell lung cancer in the PLCO cancer screening trial
27. Genetic variants in nucleotide excision repair pathway predict survival of esophageal squamous cell cancer patients receiving platinum‐based chemotherapy
28. Associations between expression levels of nucleotide excision repair proteins in lymphoblastoid cells and risk of squamous cell carcinoma of the head and neck
29. Mouse double minute 4 variants modify susceptibility to risk of recurrence in patients with squamous cell carcinoma of the oropharynx
30. Novel genetic variants in the P38MAPK pathway geneZAKand susceptibility to lung cancer
31. Genetic variants in the metzincin metallopeptidase family genes predict melanoma survival
32. Pathway-analysis of published genome-wide association studies of lung cancer: A potential role for theCYP4F3locus
33. Novel genetic variants in HDAC2 and PPARGC1A of the CREB‐binding protein pathway predict survival of non‐small‐cell lung cancer.
34. E2F transcription factor 2 variants as predictive biomarkers for recurrence risk in patients with squamous cell carcinoma of the oropharynx
35. A functional variant at the miRNA binding site inE2F1gene is associated with risk and tumor HPV16 status of oropharynx squamous cell carcinoma
36. Genetic polymorphisms in the microRNA binding-sites of the thymidylate synthase gene predict risk and survival in gastric cancer
37. Two novelPRKCIpolymorphisms and prostate cancer risk in an Eastern Chinese Han population
38. Polymorphisms at the microRNA binding-site of the stem cell marker gene CD133 modify susceptibility to and survival of gastric cancer
39. Genetic variant rs16430 6bp > 0bp at the microRNA-binding site inTYMSand risk of sporadic breast cancer risk in non-hispanic white women aged ≤55 years
40. Combined effects ofE2F1andE2F2polymorphisms on risk and early onset of squamous cell carcinoma of the head and neck
41. Genetic variants of a BH3-only pro-apoptotic gene, PUMA , and risk of HPV16-associated squamous cell carcinoma of the head and neck
42. Single nucleotide polymorphisms of matrix metallopeptidase 3 and risk of gliomas in a Chinese Han population
43. Association between polymorphisms in the GSTA4 gene and risk of lung cancer: A case-control study in a Southeastern Chinese population
44. Overexpression ofhMTH in peripheral lymphocytes and risk of prostate cancer: a case-control analysis
45. Low-dose genistein induces cyclin-dependent kinase inhibitors and G1 cell-cycle arrest in human prostate cancer cells
46. Overexpression of hMTH in peripheral lymphocytes and risk of prostate cancer: a case-control analysis.
47. Low-dose genistein induces cyclin-dependent kinase inhibitors and G1 cell-cycle arrest in human prostate cancer cells.
48. Susceptibility loci of CNOT6 in the general mRNA degradation pathway and lung cancer risk-A re-analysis of eight GWASs.
49. Genetic variant rs16430 6bp > 0bp at the microRNA-binding site in TYMS and risk of sporadic breast cancer risk in non-Hispanic white women aged ≤ 55 years.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.